Caffeine and Vaso-occlusive Crisis Risk Its key to know how caffeine affects the risk of vaso-occlusive crises in Sickle Cell Disease (SCD)
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
L-Carnitine also plays a role in carbohydrate metabolism, meaning it may be linked with insulin resistance another characteristics feature of NAFLD
This is particularly beneficial for patients with digestive conditions or those who experience gastrointestinal intolerance to oral supplements
Notably, although plant metabolites such as berberine, emodin and curcumin have been shown in vitro to improve NAFLD symptoms by regulating hepatic lipid metabolism and inhibiting hepatocellular inflammation, they are categorized as pan-assay interference compounds (PAINS), which may generate false-positive results in vitro through non-specific mechanisms ( in vivo studies to exclude assay interference